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Abstract
Necrotizing enterocolitis continues to be a devastating disease process for very low birth weight infants in Neonatal
Intensive Care Units. The aetiology and pathogenesis of necrotizing enterocolitis are not definitively understood. It
is known that necrotizing enterocolitis is secondary to a complex interaction of multiple factors that results in
mucosal damage, which leads to intestinal ischemia and necrosis. Advances in neonatal care, including resuscitation
and ventilation support technology, have seen increased survival rates among premature neonates and a
concomitant detection in the incidence of this intestinal disease.
Diagnosis can be difficult, and identifying infants at the onset of disease remains a challenge. Early diagnosis, which
relies on imaging findings, and initiation of prompt therapy are essential to limit morbidity and mortality. Moreover,
early management is critical and life-saving.
This review summarizes what is known on the laboratory and instrumental diagnostic strategies needed to improve
neonatal outcomes and, possibily, to prevent the onset of an overt necrotizing enterocolitis.
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Background
Necrotizing enterocolitis (NEC), a condition character-
ized by intestinal necrosis affecting the ileum, jejunum
and/or colon, is a leading cause of morbidity and mortal-
ity among premature infants [1]. The term “necrotizing
enterocolitis” first appeared in the 1950s when Schmid
and Quaiser [2] described infants dying from necrotic le-
sions of the gastrointestinal tract. However, it was not
until the 1960s, when Barlow et al. [3] reported a series
of 64 infants with NEC that it became recognized as a
distinct clinical entity. The incidence varies from 0.5 to
5 per 1000 live births, but NEC is predominantly a dis-
ease of very low birth weight (VLBW) infants, with a
clinical picture of focal intestinal perforation, a distinct
subset of NEC in terms of surgical management [4, 5].
Preterm newborns have many intestinal vulnerabilities
that permit microbial pathogens to invade tissue and
cause severe morbidity and mortality [6]. Animal models
of NEC have shown that the innate immune system and,
specifically, toll-like receptor-4 are crucial components
of NEC vulnerability. This receptor recognizes lipopoly-
saccharide and is thus a potent sensor of pathogenic
bacteria overgrowth and translocation across the mu-
cous barrier of the mucosa [7]. Its pathogenesis is not
yet completely understood; several risk factors have been
reported, such as immaturity, ischemia, altered gut
microflora, decreased mucin barrier, increased gut per-
meability, reduced gut immunity, and type of enteral
feeding formula [8–11]. This multifactorial aetiology
leads to the one common final pathway of oxidative
stress, inflammation, and necrosis of the neonatal bowel
[8, 9]. Mortality rates remain high; infants who die of
NEC commonly (66%) die quickly, and new therapeutic
interventions are needed [7]. Current management in-
cludes empiric administration of broad-spectrum antibi-
otics, initiation of bowel rest, bowel decompression,
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infusion of fluid and inotropes to support cardiac func-
tion [12]. Surgical intervention is required in up to 50%
of NEC cases and includes the removal of necrotic intes-
tine, ileostomy or anastomosis [12]. To date, the primary
and most promising method of reducing NEC morbidity
lies in NEC prevention [13].
This paper summarizes what is known about the diag-
nostic strategies needed to improve neonatal outcomes
and, if possible, to prevent the onset of complicated NEC.
Laboratory diagnosis
Early and accurate identification of NEC represents the
prime objectives of clinical practice, but a truly early
diagnosis is limited by the lack of any highly sensitive
and prompt tests to detect signs of NEC and to identify
newborns who will develop this intestinal condition [13,
14]. Clinical biomarkers have not been reliable thus far
in predicting when NEC will occur or who will develop
the disease. Several biochemical alterations, such as
raised or depressed white cell count, thrombocytopenia,
metabolic acidosis, glucose instability and elevated
C-reactive protein levels, can be observed in infants af-
fected by NEC [15, 16], but none of these laboratory pa-
rameters present accurate sensitivity and specificity.
Particularly, it has been studied whether the platelet
neutrophil product could be useful in assessing the prog-
nosis of patients with NEC, either in terms of extent of
disease or survival. Ragazzi et al. constructed ROC
curves to evaluate the relationship between specificity
and sensitivity of these products; they showed an area
under the ROC curve for survival of 0.58 for neutro-
phils, 0.75 for platelets and 0.71 for and their product,
indicating that these last performed no better than initial
platelet count alone as an indicator of survival; however,
ROC curves for discriminating between patients with ei-
ther multifocal or panintestinal involvement, showed
that platelet-neutrophil product, with an area under the
curve of 0.69, performed better than either platelets
alone (0.65) or neutrophils alone (0.64) [15].
Moreover, different classes of components of the in-
flammatory cascade, such as C-reactive protein, serum
amyloid A, chemokines, cytokines, and interleukins, can
helpful in accurate diagnosis or predicting the severity
and evolution of NEC [17].
Yang et al. investigated the diagnostic value of
pre-albumin in neonates with severe NEC, demonstrat-
ing that this biomarker could be an important value for
the diagnosis of severe NEC (≥IIB) with high sensitivity
and specificity [18].
There are also other more specific markers of intes-
tinal damage, such as intestinal fatty acid-binding pro-
tein (I-FABP) [19, 20], which is released into the
circulation from damaged enterocytes and excreted in
urine, but these are not yet suitable for routine clinical
use. Liebermann et al. reported that plasmatic levels of
I-FABP might serve as a diagnostic marker for early in-
testinal mucosal compromise, such as NEC [21]. Several
studies found plasmatic concentrations of I-FABP to be
a specific marker for early identification of severe NEC
(Bell’s stage III), but less useful for differentiating initial
Bell’s stages [22, 23]. Regarding the potential diagnostic
value of I-FABP measured in plasma (I-FABPp) and
urine (I-FABPu) for the detection of NEC, Schurink et
al. demonstrated that a sensitivities for both I-FABPp
and I-FABPu dropped to 11–77% and 5–50% respect-
ively, with specificities soon equalling 100% [24]. There-
fore, the specificity for I-FABP to determine whether
patients would develop complicated NEC gradually in-
creased over time, ranging from 75% at onset of disease
to 91% after 48 h [24]. However, concentration in
healthy premature infants is very variable and half-life in
plasma is short, so that use of I-FABP concentration in
plasma or urine to diagnose early NEC is limited. There-
fore, I-FABP can to be used to identify infants that have
advanced disease and who might thus require more exten-
sive resection [25]. Besides, the recent multicenter study
conducted by Heida et al. demonstrated that both plasma
and urine I-FABP levels are strongly associated with the
length of bowel resection in newborns with surgical NEC,
supporting the hypothesis that increased I-FABP levels
correspond with the extent of necrotic tissue [25].
Recently, other innovative biomarkers, such as the urin-
ary proteome [26] and peptidome [27] have been identi-
fied and have been related with poor outcome, including
disease progression, but these biomarkers alone were not
able to distinguish progressors from non-progressors.
However, these biomarkers, along with other clinical fac-
tors, could predict the clinical subset of NEC [26, 27].
Claudins, tight junction proteins, have been identified as
potential biomarkers for inflammatory bowel disease in
adult patients as well as for intestinal injury in mouse
models. Recently, it has been shown that urinary claudin-2
presented elevated levels in neonates with NEC as com-
pared to those without NEC; therefore, this molecule could
represent a potential predictor of early NEC [28].
Based on several investigations, it has been demon-
strated that acute intestinal ischemia, reperfusion and
bacterial colonization were associated with failure of the
mucosal barrier, increasing permeability of the intestinal
wall and, thus, allowing D-lactate to enter the portal cir-
culation with increased plasma D-lactate levels in both
portal and systemic blood [29]. Previously, Garcia et al.
found that urinary D-lactate increased in infants with
NEC and demonstrated increased enteric bacterial activ-
ity in NEC [30]. Recently, Guofeng et al. have examined
levels of plasma D-lactate in premature infants affected
by NEC, finding them significantly increased early, in
direct proportion to the overall extent of intestinal
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disease, without specify sensitivity and specificity [31].
Authors hypothesized that the use of plasma D-lactate
levels as a marker of intestinal injury could be useful as
a diagnosis indicator in the early stage of NEC.
Another test adopted by many NICUs was routine fae-
cal occult blood (FOB), based on the hypothesis that in-
testinal injury and inflammation associated with NEC
would lead to occult blood in the feces [32]. Abramo et
al. performed a prospective blinded study testing for oc-
cult hematochezia within the first six weeks of life in 95
neonates with birth weights < 1800 g who were receiving
at least some enteral feeds. Fifty-eight percent of the in-
fants had one or more positive FOB results during the
first six weeks of life, and the incidence of NEC was
higher in those infants with negative FOB (9.8%) than in
those with positive FOB (3.7%). Therefore, they con-
cluded that occult hematochezia was frequent in this
population and did not seem to be related to NEC, dem-
onstrating poor sensitivity, specificity, and predictive
values of FOB testing on NEC diagnosis [33]. Lately,
Pickering et al. have evaluated the value of routine FOB
testing on the identification of VLBW infants with NEC.
They demonstrated that positive FOB testing occurred
in a majority of VLBW infants, with higher odds in the
more preterm and intrauterine growth restriction, but
the sensitivity, specificity, and predictive value of routine
FOB testing for identifying NEC were all very poor, con-
cluding that this test offers no advantages in the early
diagnosis of NEC [34].
To date, to our knowledge, none biomarkers men-
tioned above present the characteristics of the “ideal bio-
marker”, that is a well-defined optimal cut-off level, a
sensitivity and negative predictive value approaching
1.00, specificity and positive predictive value > 0.85, as
well as daily or on-demand availability in routine clinical
laboratories [17].
Imaging diagnosis
Imaging modalities used with neonates during the active
phase of NEC include plain abdominal radiography and,
recently, abdominal sonography. Radiographic imaging is
essential in the diagnosis of NEC. Bell’s clinical staging of
NEC was published in 1978 and was a major force that fa-
cilitated grouping of NEC into patient cohorts rather than
as case reports and series [35]. Bell’s Criteria has been the
mainstay for the diagnosis and staging of NEC for the last
three decades. However, Bell’s staging has been modified
by Walsh and Kliegman [36], who divided each stage into
two subcategories, and included signs that differentiate
between milder and more severe courses of disease, such
as absent bowel sounds, abdominal tenderness and ascites,
as well as laboratory parameters indicative of acidosis,
thrombocytopenia, neutropenia and disseminated intra-
vascular coagulation [36]. Successively, a new ANID
taxonomy, sometimes called Gordon’s classification was
ideated [37]; although, Bell Staging continues to be used
as the standard of practice to diagnose, stage, and treat
NEC [35]. The most important radiographic findings of
plain abdominal radiography to confirm diagnosis of NEC
are pneumatosis intestinalis, portal venous gas and pneu-
moperitoneum [38]. Seminal breakthroughs have occurred
in this decade, such as ventilation support and total paren-
tal nutrition, and with them a “new NEC” has emerged in
increasingly premature infants who have survived because
of these technologies. Once patients are diagnosed with
definitive NEC (Bell’s stage 2), significant intestinal injury
is likely to occur. Therefore, it is possible that earlier de-
tection of intestinal injury and appropriate treatment
might prevent the progression of this disease [39]. Plain
abdominal radiography remains the main diagnostic tool
in the diagnosis and follow-up of NEC. However, it is
sometimes impossible to expose patients to consecutive
episodes of radiation. Ultrasound examination (US) seems
to be an alternative to current standard usage of radiog-
raphy [40]. US is an ideal modality for evaluating bowel
necrosis as it is non-invasive, does not involve the use of
ionizing radiation and can be performed readily at the
bedside. Many studies emphasized the numerous advan-
tages of US over plain abdominal radiography, including
no exposure to ionizing radiation, no limitation on fre-
quent use, availability, possibility of use at patient’s bed-
side, possibility of evaluating indices of bowel dynamics,
bowel wall thickness, echogenicity, pneumatosis intestina-
lis, rate of bowel wall perfusion, ability of determining the
nature, and estimating the amount, of intra-abdominal li-
quid [41, 42], but its role is still underestimated and plain
radiology remains the gold standard modality for diagnos-
tic purposes. Pneumatosis intestinalis and portal venous
gas are both seen during abdominal US, detected earlier
than by plain radiography [43]. Moreover, US permits
visualization of the bowel wall in a much more detailed
way than is possible with plain radiographs, with an as-
sessment of the thickness and perfusion of the intestinal
wall and peristalsis; moreover, other information, such as
the presence of free intraabdominal gas and the presence
of any free intraabdominal fluid, indicative of intestinal
perforation, can be obtained from abdominal US [44].
Ultrasonic findings can also contribute to the prediction
of the severity of NEC. Yang et al. investigated the value of
abdominal US in diagnosing NEC and its significance in
evaluating disease severity [45]. According to the modified
Bell-NEC staging criteria, authors enrolled 84 neonates, 44
with suspected NEC and 40 with confirmed NEC; accord-
ing to clinical prognosis, they were divided into a medical
treatment (n = 58) and a surgery/death group (n = 26), and
changes in the results of abdominal ultrasound and abdom-
inal X-ray plain film between groups were compared. In the
confirmed NEC group, abdominal US showed significantly
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higher detection rates of portal venous gas and dilatation
of the intestine than abdominal X-ray plain film; com-
pared with the medical treatment group, the surgery/death
group had significantly higher detection rates of dilatation
of intestine, bowel wall thickening, peritoneal effusion and
free intraperitoneal air (P < 0.05). Furthermore, dilatation
of the bowel and free intraperitoneal air shown by abdom-
inal X-ray plain film were more common in the surgery/
death group. Therefore, authors concluded that ultrasonic
findings could permit predicting the severity of NEC [45].
In another study, it has been stated that abdominal US
and radiography in patients with NEC can help predict
the outcome [46].
Until today, it was unclear from scientific literature if
bowel US findings could provide useful prognostic informa-
tion to help guide clinical decision-making. Recently, it has
been reported that bowel US may be useful for early identi-
fication of high-risk infants who may benefit from surgery
treatment [47]. Authors conducted a meta-analysis with the
identification of several bowel US characteristics associated
with poor outcomes in infants with NEC. It has been dem-
onstrated that bowel US features most strongly associated
with surgery or death were free air, absent peristalsis, com-
plex ascites and focal fluid collection; while, other minor
features, as bowel wall thinning, increased bowel wall echo-
genicity, absent perfusion and dilated bowel were correlated
with a moderate association with surgery treatment or
death. Therefore, all these findings could suggest important
addition bowel US that may help identify infants at
high-risk for poor outcomes [47].
Pneumoperitoneum, detected by abdominal radiography,
is the only sign that has been universally agreed on as an in-
dication for surgery [48]; however, this is not present in all
babies with bowel necrosis and perforation. Furthermore,
colour Doppler US is more accurate than abdominal radi-
ography in depicting bowel necrosis in NEC [49]. The ab-
sence of bowel wall perfusion at colour Doppler US is
more sensitive and specific than the presence of free air at
abdominal radiography in the detection of necrotic bowel
in NEC [49]. Faingold et al. showed that colour Doppler US
is more sensitive and specific than abdominal radiography
in the detection of necrotic bowel [38]. Abnormal US and
radiography findings were the most powerful predictors of
the need for surgical intervention, including persistent dila-
tion of the bowel loops and evidence of portal venous gas,
which were detected by radiography, and bowel wall thick-
ening, absent peristalsis and echogenic-free fluid or focal
fluid collection, which were detected by ultrasonography.
Therefore, the presence of both echogenic fluid and focal
fluid have been reported to be indicators for surgical inter-
vention [50]. Other studies have also evaluated the use of
computed tomography and magnetic resonance imaging,
but these modalities have not been found to be useful in
clinical practice [51, 52].
Conclusion
NEC diagnosis most often relies on a combination of clin-
ical symptoms and signs, including feeding intolerance,
abdominal distention and bloody stools, and radiological
features, such as pneumatosis intestinalis, portal venous
gas and pneumoperitoneum [14]. Although improvements
in the prevention, diagnosis, and treatment of NEC have
been made, the only effective strategy is developing a
multidisciplinary programmatic approach to reducing
NEC. Personalized treatment strategies would be the ideal,
but will not be readily available until “ideal” predictive and
diagnostic biomarkers have been discovered. Also imaging
diagnosis has evolved. It has been documented that com-
bining abdominal radiography and ultrasonography are, to
date, the techniques that together could predict the need
for surgical intervention [53].
In conclusion, several studies are needed to discover
therapeutic strategies to attenuate uncontrolled inflam-
matory reaction and provide other medical opportunities
to treat NEC, before it evolves into a serious sepsis [54].
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